FBN1 and Marfan syndrome: Initially, increased TGF-β was thought to drive AAA pathogenesis, based on mouse models of Marfan syndrome (MFS), where fibrillin 1 (FBN1) mutations led to enhanced activation of latent TGF-β [75].